Hepatitis B virus genetics and drug resistance study
Part of Digestive system, Infections clinical trials.
This study looks at how hepatitis B virus changes in your body, including mutations and drug resistance, using your blood or liver tissue samples. Understanding these changes could help improve treatment for hepatitis B.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have hepatitis B (positive for hepatitis B surface antigen).
- You must have your full medical information and stored blood or liver tissue samples available.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a newer, more precise way of measuring the amount of hepatitis B virus in your blood (called digital PCR) to see if it matches current testing methods. If you are a chronic hepatitis B patient, this could help make future virus monitoring more accurate.
This study looks at genetic factors that may help people with chronic hepatitis B achieve a clinical cure when treated with long-acting interferon. It aims to find out why some patients respond better than others.
This study collects a small sample of liver cells to understand how hepatitis B virus behaves in the liver and how the immune system responds. This could help improve future treatments for chronic hepatitis B.
This study looks at how a specific protein (ANKRD11) affects immune cells in people with chronic hepatitis B. By understanding this, researchers hope to find ways to help your immune system fight the virus better.
This study looks at whether metabolic syndrome (a group of conditions like obesity, high blood pressure, and diabetes) affects how well antiviral treatment works for people with chronic hepatitis B. It may help doctors personalize treatment for people with both conditions.
This study looks at the genes of people with chronic hepatitis B (HBV) to find why some people's immune cells (B cells and NK cells) stop working properly. The goal is to discover new ways to treat the disease.
Hear when a new Chronic Hepatitis B trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.